Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

lupus nephritis

GSK teams up with Vodafone for mHealth initiative

Aims to use mobile technology to improve childhood vaccination rates in Mozambique

- PMLiVE

GSK raises stake in Nigerian unit

Set to expand in growing market

- PMLiVE

GSK consumer puts six-figure Day+Night Nurse campaign with Time Out London

Day+Night Nurse brand gets multi-media push with Time Out campaign developed by Grey London and MediaCom

- PMLiVE

Ligand/GSK’s Promacta cleared for hep C in US

New FDA approval is expected to open up a significant new market for the drug

- PMLiVE

Pharma’s growing ease with social media

GSK's participation last week in a Twitter chat is a sign of how comfortable the industry has become with social media

- PMLiVE

GSK’s malaria vaccine effects ‘modest’ in infants

Less than expected efficacy findings surprise researchers

- PMLiVE

UK to use GSK’s Rotarix in rotavirus vaccination programme

Chosen ahead of Merck & Co’s RotaTeq

- PMLiVE

GSK and XenoPort end restless legs syndrome collaboration

Follows tough approval period for Horizant and subsequent poor sales 

- PMLiVE

GSK sales drop as austerity measures hit business in Europe

Revenues in region drop 9 per cent

- PMLiVE

GSK takes severe asthma antibody into phase III

Mepolizumab could help patients who cannot prevent attacks using current therapies

- PMLiVE

Sir Christopher Gent ‘stepping down’ as GSK chair

He will leave the pharma firm in the next two or three years, according to a UK press report

- PMLiVE

GSK, Pfizer and Shionogi rewrite HIV joint venture terms

Comes ahead of first regulatory submissions for lead drug candidate dolutegravir

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links